Research roundup

Debbie Rigby 18/08/2025

Debbie Rigby takes a look at the latest in research news Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications Recent evidence indicates that after discontinuing glucagon-like peptide 1 receptor agonists for obesity, body weight initially continues to decrease for four weeks but then gradually increases, with significant weight regain

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research roundup

Previous A guide to a business planning workshop with your team

Next Reaching out for feedback on services

MENU

ajp.com.au

Previous A guide to a business planning workshop with your team

Next Reaching out for feedback on services

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.